Muhammed Bülent Akıncı

6PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 27, 2026
Prognostic Value of the Lung Immune Prognostic Index in Metastatic Renal Cell Carcinoma Treated With Second-Line Immunotherapy.

|Nov 27, 2025
Elderly Men with De Novo Metastatic Castration-Sensitive Prostate Cancer: Therapy and Does Comorbidity Matter.

Ugur Ozberk, Selin Akturk Esen, Alican Uguz

|Jul 21, 2025
Comparative efficacy of adjuvant FOLFOX vs. FLOT following neoadjuvant FLOT in patients with locally advanced gastric cancer.

Furkan Ceylan, Didem Şener Dede, Safa Can Efil

|Jun 26, 2025
Induction or Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer Receiving Chemoradiotherapy? A Turkish Oncology Group Study.

Serhat Sekmek, Aysel Oguz, Melek Karakurt Eryilmaz

|Feb 13, 2025
Palliative Radiotherapy in Metastatic Breast Cancer Patients on CDK4/6 Inhibitors: Safety Analysis.

Furkan Ceylan, Mirmehdi Mehdiyev, Burak Bilgin

|Jan 11, 2025
Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer.

Furkan Ceylan, Mirmehdi Mehdiyev, Didem Şener Dede

Pageof 1

Frequent Collaborators

4 joint publications

Dogan Uncu

3 joint publications

Furkan Ceylan

3 joint publications

Ateş Kutay Tenekeci

3 joint publications

Bülent Yalçın